Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management, but now widely recognized for its significant weight loss effects. Recent clinical trials demonstrate that individuals using semaglutide achieve reductions of approximately 15-22% of body weight over 68 weeks. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, making this treatment accessible nationwide without requiring insurance or membership fees.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors in the brain regions responsible for appetite control and satiety signaling. When these receptors are activated, the hormone sends signals that reduce hunger intensity and increase feelings of fullness after smaller meal portions. This mechanism occurs naturally in the body during digestion, but semaglutide amplifies these signals to create sustained appetite suppression throughout the day.

The medication also slows gastric emptying, meaning food moves through your stomach more gradually, prolonging the sensation of satisfaction between meals. Additionally, semaglutide influences blood sugar regulation and may enhance insulin sensitivity, contributing to metabolic improvements beyond weight reduction alone. These combined effects work together to create a powerful yet natural-feeling approach to weight management that doesn't rely on stimulants or extreme dietary restriction.

Clinical Evidence: Real Weight Loss Results

The STEP trials, landmark clinical studies published in the New England Journal of Medicine, tracked over 4,500 adults with obesity or overweight conditions over 68 weeks. Participants receiving semaglutide lost an average of 10-12 kg (22-26 lbs) more than those on placebo, with many achieving 15-22% total body weight reduction. These results were sustained even after accounting for lifestyle modifications, demonstrating semaglutide's independent contribution to weight loss success.

Beyond weight loss alone, clinical data showed improvements in cardiovascular markers, blood pressure reduction, and enhanced metabolic profiles in participants using semaglutide. Studies also indicate that people maintain weight loss better when continuing the medication compared to discontinuation, suggesting lasting metabolic adaptation occurs during treatment. These evidence-based outcomes have made semaglutide one of the most extensively studied weight loss medications available today.

Semaglutide Dosing and Your Personalized Treatment Plan

Semaglutide treatment typically begins with a low starting dose, which is gradually increased over several weeks to allow your body to adjust and minimize potential side effects. Most protocols begin at 0.25 mg weekly, with increases occurring every 4 weeks until reaching an effective maintenance dose, which often ranges from 1.0 to 2.4 mg weekly. The specific dose progression is determined by your individual response, tolerance level, and weight loss goals in collaboration with your PlexusDx clinician.

PlexusDx offers compounded semaglutide injections at a flat monthly rate starting at $149/month—your dose may need to go up, but your price won't increase as your treatment progresses. This transparent pricing model eliminates the financial uncertainty often associated with dose escalation. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on), which analyzes your GLP1R rs6923761 variant and 48 additional peptide-pathway markers to help predict your individual response potential and guide personalized dosing strategies.

Semaglutide Side Effects and Safety Considerations

The most commonly reported side effects include mild-to-moderate gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, particularly during the initial weeks of treatment or after dose increases. These effects typically diminish within several days to a week as your body adapts, and they can often be managed through dietary adjustments like eating smaller, lower-fat meals. Serious adverse events are rare in clinical trials, and semaglutide has a well-established safety profile when prescribed by qualified healthcare providers.

PlexusDx clinicians perform thorough health assessments before initiating semaglutide to identify any contraindications, such as personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). The medication is administered as a weekly subcutaneous injection, which most patients find convenient and painless when using the provided auto-injection devices. Ongoing monitoring through PlexusDx includes regular check-ins to assess efficacy, side effect management, and any necessary dose adjustments throughout your treatment journey.

Why Choose PlexusDx for Compounded Semaglutide?

PlexusDx partners exclusively with licensed 503A compounding pharmacies, which are state-regulated facilities subject to stringent quality, sterility, and potency standards established by state boards of pharmacy. Unlike 503B commercial operations, 503A compounders prepare medications under pharmaceutical-grade conditions specifically for individual patient prescriptions. All compounded semaglutide from PlexusDx pharmacies undergoes rigorous quality assurance to ensure consistency and safety equivalent to brand-name medications.

Access through PlexusDx eliminates common barriers to GLP-1 therapy: no insurance is required, no membership fees apply, and treatment is available in all 50 states with convenient home delivery. HSA and FSA accounts are eligible for payment, increasing financial flexibility for participants. PlexusDx clinicians provide ongoing support throughout your weight loss journey, adjusting your treatment plan based on your progress, response, and any lifestyle or health changes that emerge during therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide?

Most patients notice initial changes in appetite and food intake within the first 1-2 weeks, with measurable weight loss typically appearing by week 3-4 of consistent treatment. Substantial weight loss (5-10% of body weight) generally occurs within 8-12 weeks, though individual timelines vary based on starting weight, metabolism, and adherence. ...

Is semaglutide safe for long-term weight loss maintenance?

Clinical evidence supports semaglutide as a safe long-term treatment option, with studies tracking safety and efficacy over 68+ weeks showing sustained benefits without concerning accumulation of adverse events. Participants who discontinue semaglutide typically regain weight gradually, suggesting that ongoing therapy maintains the metabolic ben...

What is the cost of semaglutide through PlexusDx?

Compounded semaglutide injections start at $149/month through PlexusDx, with pricing remaining flat regardless of your dose level. PlexusDx accepts HSA and FSA payments, requires no insurance or membership fees, and delivers nationwide. Add the Precision Peptide Genetic Test ($99 one-time add-on after your first month) to personalize your treatm...

Can I use semaglutide if I have medical conditions or take other medications?

Semaglutide is contraindicated in certain conditions, including personal or family history of thyroid cancer and multiple endocrine neoplasia type 2 (MEN2). PlexusDx clinicians conduct comprehensive health reviews before prescribing and screen for medication interactions with your current treatments. Always inform your provider of all medical co...

How does the Precision Peptide Genetic Test help with semaglutide treatment?

PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R rs6923761 variant, along with 48 additional peptide-pathway genetic markers spanning 14 biological pathways, to reveal how your genetics influence GLP-1 receptor sensitivity and weight loss response. This genetic insight helps your PlexusDx clinician personalize your initial dosing st...

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves